Prostock-Studio/iStock via Getty Images ZimVie ( NASDAQ: ZIMV ) soared 19% after a report that the dental implants maker is considering a sale after takeover approaches. The company is working with an adviser to review alternatives after getting interest from possible acquirers including private equity firms and industry players, according to a Bloomberg report on Tuesday, which cited people familiar with the matter. Deliberations are at an early stage and ZimVie ( ZIMV ) may decide not to pursue a sale.
ZimVie, which was spun off from Zimmer Biomet in 2022, has a market cap of over $400 million. More on ZimVie ZimVie: Guidance Suggests Company Fairly Valued At The Moment (Rating Downgrade) ZimVie Inc. (ZIMV) Q1 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on ZimVie Historical earnings data for ZimVie Financial information for ZimVie.
